Projects funded by the NCN
New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epilepsy and neuropathic pain.
2021/41/N/NZ7/01181
Keywords:
hybrid compounds multifuncional drugs epilepsy neuropathic pain anticonvulsant activity antinociceptive activity
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 20 - announced on 2021-03-15
Amount awarded: 209 940 PLN
Project start date (Y-m-d): 2022-01-26
Project end date (Y-m-d): 2025-01-25
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.